Skip to main navigation
logo
  • Investors Overview
  • Financial Releases
  • Events & Presentations
  • Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Results
  • Stock Info
    • Stock Quote & Chart
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • IR Resources
    • Investor FAQs
    • Email Alerts
    • Contact Us

Financial Releases

11 Jan '23
Lifecore Biomedical Receives Notice from Nasdaq Regarding Delayed Quarterly Report
CHASKA, Minn. , Jan. 11, 2023 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (“Lifecore” or the “Company”), announced today that it received a notice (“Notice”) on January 11, 2023 from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in
09 Jan '23
Lifecore Biomedical Raises Capital with Private Placement of Convertible Preferred Stock; Amends Credit Facilities
$38.75 million Private Placement of Series A Convertible Preferred Stock to Support Working Capital and Capital Expenditures While Pursuing Ongoing Divestment Process of non-CDMO Assets Credit Facilities Amended to Increase Liquidity and Provide Financial Covenant Relief Nathaniel Calloway, PhD and

Shareholder Tools

  • Investor FAQs
  • Email Alerts
  • Contact Us

© 2023 Lifecore Biomedical. All rights reserved.